Blog

Marc Jopek, Vice President, Strategic Development

Interoperability a clear need for HIMSS22 attendees

Marc Jopek

by MARC JOPEK

VICE PRESIDENT SALES, EMEA, Rhapsody

HIIMSS22 Day 3 was again a successful day with 46 qualified meetings. 

We were expecting that the meeting frequency would be down to zero after lunch time, but we had several visitors even after lunch. 

U.S. and international potential customers were still attending discussions and demos. 

It was my first time to attend HIMSS, so I cannot benchmark quantity of meetings to past exhibitions, but based on my meetings I had during the last three days I was positively surprised about the quality of meetings and the constructive feedback and follow-up requests from potential new customers.  

At Rhapsody, we’re solving healthcare interoperability challenges one whiteboard session at a time.

Overall interoperability needs are still an existing priority and pain point. The Rhapsody portfolio and solutions 100% match these requirements. With the expansion of the portfolio with NextGate solutions, we are even more in the position to answer all interoperability requirements to build connections for a healthier world. 

Read our HIMSS Recap Day 1 and HIMSS Recap Day 2

Register to join our interactive webinar, Let’s talk about ViVE and HIMSS 

Related Blogs

Rhapsody Health Solutions Team

Where Interoperability Strategy Falls Short—And How to Fix It 

Too many tools. Not enough trust. Discover the 5 biggest mistakes CIOs make in healthcare interoperability—and what to do instead. Download the full whitepaper.

Read More >

Read more

Rhapsody Health Solutions Team

Introducing Rhapsody Auto Migrate: Enabling Fast, Easy, and Low-Risk Migration from Cloverleaf 

Discover how Rhapsody Auto Migrate simplifies and accelerates your migration from Cloverleaf to Rhapsody with minimal risk and downtime.

Read More >

Read more
Business man with smile in modern office

Rhapsody Health Solutions Team

Don’t Leave Person Data to Chance: Use AI

Poor quality person data leads to flawed analytics, compliance risks, and lost trust. A next-gen EMPI ensures accuracy, compliance, and growth at scale.

Read More >

Read more